ECM Archives - Page 11 of 15 - Bryan, Garnier & Co

Celyad 2015 tombstone

Bryan, Garnier & Co announces the successful $100m Nasdaq IPO of Celyad.

Galapagos tombstone

Bryan, Garnier & Co announces that the total proceeds of Galapagos IPO on Nasdaq, the largest Nasdaq IPO of a European biotech, have been raised to $317m following the full exercise of over-allotment option.

Advanced Oncotherapy tombstone

Bryan, Garnier & Co announces the successful follow-on offering of £20m for Advanced Oncotherapy plc

Bone Therapeutics 2015 tombstone

Bryan, Garnier & Co announces the successful IPO of Bone Therapeutics.

Quantum Pharma tombstone

Bryan, Garnier & Co announces the IPO of Quantum Pharma on London AIM

Erytech 2014 tombstone

Bryan, Garnier & Co acts as Global Coordinator and Bookrunner of a Follow-on Offering of €30m for Erytech Pharma

DBV 2014 tombstone

Bryan, Garnier & Co acts as Joint Lead Manager and Joint Bookrunner of DBV $133m IPO on NASDAQ.

Voltalia 2014 tombstone

Bryan, Garnier & Co advises Voltalia on its transfert to Euronext and €100m Capital Increase

ASK tombstone

Bryan, Garnier & Co acts as Lead Manager and Sole Bookrunner on ASK’s EUR 22m IPO on Euronext

LDR tombstone

Bryan, Garnier & Co acts as Co-manager of LDR 97m$ follow-on offering on NASDAQ.

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }